Agilent Technologies has agreed to buy the Danish cancer diagnostics company Dako, which is currently owned by the Swedish private equity group EQT Partners, for US$2.2 B. The acquisition, which represents the largest deal in Agilent’s history, is the company’s latest attempt to expand its life sciences business and will complement its existing diagnostics portfolio.